ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Treating OSD in 2024"
Episode Synopsis
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, kick off 2024 with a conversation about several new and anticipated products for treating ocular surface disease, including cyclosporine ophthalmic solution 0.1% (Vevye, Harrow), perfluorohexyloctane ophthalmic solution (Meibo, Bausch + Lomb), and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals). They also share some practice pearls and professional goals for the year ahead.
More episodes of the podcast To the Point
A Year of Dry Eye Innovation
18/12/2025
Clinical Pearls for Autologous Serum Drops
12/11/2025
Aesthetics and the Ocular Surface
24/10/2025
Running a Standalone Dry Eye Clinic
10/09/2025
Takeways From the TFOS DEWS III Report
08/07/2025
A Lesson in Blink Mechanics and Dry Eye
11/06/2025
Is it Dry Eye or Corneal Pathology?
12/05/2025
Take Ownership of Your Career in Dry Eye
09/04/2025
In God we trust